Fundraising Fox
Surface Ophthalmics
Pleasanton, US · Founded 2017 · Delaware corporation
Find your way into Surface Ophthalmics
Sign up to see every warm intro you have to Surface Ophthalmics
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Surface Ophthalmics team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Surface Ophthalmics is a biopharmaceutical company developing topical eyedrop treatments for dry eye syndrome and post-surgical ocular conditions. The company has evaluated multiple formulations through Phase II clinical trials and is pursuing three proprietary candidates for commercialization.
Founders & leadership
Board
MB
JA
J. Andy CorleyBoard director
ST
Shelley ThunenBoard director
AG
Adrienne GravesBoard director
RL
Richard LindstromBoard director
Reported raises · per SEC filings
Form D private placements$40.1M disclosed across 2 rounds · 2018–2021
▶$25.1MraisedAug 2021 · 444 investors · Other Health CareRule 506(b)
▶$25.1MraisedAug 2021 · 444 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Mark BaumDirector
- Kamran HosseiniExecutive Officer, Director
- Shelley ThunenDirector
- Adrienne GravesDirector
- Perry SternbergExecutive Officer, Director
- Richard LindstromDirector
- J. Andy CorleyDirector
- Offering amount
- $30.6M
- Amount sold
- $25.1M
- Finders' fees
- $1.5M
- Placement agents
- Newbridge Securities Corporation
- First sale
- May 2021
- Incorporated
- Corporation, Delaware, 2017
- Federal exemptions
- 06b
▶$15MraisedMay 2018 · 1 investors · PharmaceuticalsRule 506(b)
▶$15MraisedMay 2018 · 1 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- Richard L. LindstromDirector
- Louis DrapeauDirector
- Adrienne GravesDirector
- Kamran HosseiniExecutive Officer, Director
- Mark BaumExecutive Officer, Director
- J. Andrew CorleyDirector
- Offering amount
- $20M
- Amount sold
- $15M
- First sale
- May 2018
- Incorporated
- Corporation, Delaware, 2017
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Related companies · 5
Hilco VisionHilco Vision manufactures and distributes lens care products including cleaners, wipes, and protective accessories for eyewear. The company serves optical practices and eyewear retailers with both standard and custom-branded solutions.
OisOIS is a conference and community, active since 2009, focused on eye care and ophthalmology innovation, connecting startups, strategics, investors, and clinicians. It provides curated programming, networking, and access to new technologies in the ophthalmology industry.
AlconAlcon develops eye care products and medical technologies, including the Valeda Photobiomodulation (PBM) system for retina treatment, for eye care professionals such as retina specialists.
StuarttherapeuticsStuart Therapeutics is a clinical-stage pharmaceutical company developing synthetic collagen mimetic peptides (its PolyCol platform) designed to bind and repair damaged helical collagen in the extracellular matrix. Its therapies target chronic eye diseases including dry eye disease, glaucoma, and inherited retinal disorders such as retinitis pigmentosa and age-related macular degeneration.
ZocdocZocdoc runs an online marketplace where US patients find in-network doctors and dentists and book in-person or telehealth appointments.
Companies working in the same space as Surface Ophthalmics.
In the news
Frequently asked questions
- What does Surface Ophthalmics do?
- Surface Ophthalmics is a biopharmaceutical company developing topical eyedrop treatments for dry eye syndrome and post-surgical ocular conditions. The company has evaluated multiple formulations through Phase II clinical trials and is pursuing three proprietary candidates for commercialization.
- How much funding has Surface Ophthalmics raised?
- Surface Ophthalmics has disclosed $40.1M raised across 2 rounds.
- Where is Surface Ophthalmics headquartered?
- Surface Ophthalmics is headquartered in Pleasanton, US.